Aller au contenu principal
Accès ouvert déclaré 2024 article

A PSA SNP associates with cellular function and clinical outcome in men with prostate cancer

15Citations signalées, ce qui n’est pas une note de qualité
155Institutions déclarées
19Pays d’affiliation déclarés

Rattachement africain : au, gb, nl, es, is, pl, no, us, fi, de, se, fr, dk, hr, be, ca, pt, my, bg. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Genetic variation at the 19q13.3 KLK locus is linked with prostate cancer susceptibility in men. The non-synonymous KLK3 single nucleotide polymorphism (SNP), rs17632542 (c.536 T > C; Ile163Thr-substitution in PSA) is associated with reduced prostate cancer risk, however, the functional relevance is unknown. Here, we identify that the SNP variant-induced change in PSA biochemical activity mediates prostate cancer pathogenesis. The 'Thr' PSA variant leads to small subcutaneous tumours, supporting reduced prostate cancer risk. However, 'Thr' PSA also displays higher metastatic potential with pronounced osteolytic activity in an experimental metastasis in-vivo model. Biochemical characterisation of this PSA variant demonstrates markedly reduced proteolytic activity that correlates with differences in in-vivo tumour burden. The SNP is associated with increased risk for aggressive disease and prostate cancer-specific mortality in three independent cohorts, highlighting its critical function in mediating metastasis. Carriers of this SNP allele have reduced serum total PSA and a higher free/total PSA ratio that could contribute to late biopsy decisions and delay in diagnosis. Our results provide a molecular explanation for the prominent 19q13.3 KLK locus, rs17632542 SNP, association with a spectrum of prostate cancer clinical outcomes.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
A PSA SNP associates with cellular function and clinical outcome in men with prostate cancer
Date Crossref
06/11/2024
Éditeur
Springer Science and Business Media LLC
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Translational Research InstituteQueensland University of TechnologyThe University of QueenslandMater ResearchFlorey Institute of Neuroscience and Mental HealthBond UniversityPrincess Alexandra HospitalSunshine Coast University HospitalRoyal Marsden NHS Foundation TrustInstitute of Cancer ResearchErasmus MCSpanish National Cancer Research CentreCentro de Investigación del CáncerUniversity of SouthamptonSt Mary's HospitalUniversity of IcelandImperial College Healthcare NHS TrustUniversity of LiverpoolUniversity of OxfordJohn Radcliffe HospitalNational University Hospital of IcelandWalter and Eliza Hall Institute of Medical ResearchInternational Hereditary Cancer CenterOslo University HospitalMedway Maritime HospitalUniversity College London Hospitals NHS Foundation TrustUniversity College LondonQueen Mary University of LondonGuy's HospitalWessex Regional Genetics LaboratoryNottingham City HospitalInnovate UKFundación Pública Galega de Medicina XenómicaServicio Gallego de SaludUniversity of CambridgeUniversity of BristolCedars-Sinai Medical CenterRadboud University NijmegenBarts Health NHS TrustSt George’s University Hospitals NHS Foundation TrustCambridge University Hospitals NHS Foundation TrustUniversity of East AngliaUniversity of TurkuTurku University HospitalPraxis für Humangenetik TübingenManchester Academic Health Science CentreUniversity of ManchesterFred Hutch Cancer CenterKarolinska InstitutetNational Cancer InstituteDivision of Cancer Epidemiology and GeneticsUniversity of WashingtonHarvard UniversitySorbonne UniversitéAssistance Publique – Hôpitaux de ParisHôpital TenonOnco-Urologie PrédictiveAarhus University HospitalUniversity of Southern CaliforniaThe University of MelbourneCancer Council VictoriaCentre for Biomedical Network Research on Rare DiseasesInstituto de Investigación Sanitaria de SantiagoInstituto de Investigación de Enfermedades RarasCancer Research UKAddenbrooke's HospitalCentro de Investigación Biomédica en Red de Epidemiología y Salud PúblicaBrigham and Women's HospitalUniversitat Pompeu FabraHospital Del MarMunicipal Institute for Medical ResearchBarcelona Institute for Global HealthUniversity of CopenhagenGentofte HospitalGerman Cancer Research CenterHeidelberg UniversityStanford UniversityUniversity of ZagrebKU LeuvenLund UniversityUmeå UniversityKarolinska University HospitalIcahn School of Medicine at Mount SinaiQIMR Berghofer Medical Research InstituteUniversity of HelsinkiHelsinki University HospitalMemorial Sloan Kettering Cancer CenterUniversity Hospitals Seidman Cancer CenterCase Western Reserve UniversityAmerican Cancer SocietyThe Christie HospitalThe Christie NHS Foundation TrustUniversity of TorontoPrincess Margaret Cancer CentreMonash HealthMonash UniversityMoffitt Cancer CenterPomeranian Medical UniversityThe University of Texas MD Anderson Cancer CenterUniversidade do PortoInstituto Português de Oncologia Francisco GentilIPO PortoCity of HopeBeckman Research InstituteGhent UniversityUniversity of MalayaUniversität HamburgUniversity Medical Center Hamburg-EppendorfMedical University of SofiaUniversity of AlbertaHealth Innovation ManchesterNIHR Manchester Biomedical Research CentreUniversity Hospital Complex Of VigoUniversity of SurreyComplexo Hospitalario Universitario A CoruñaInsermUniversité Paris-SaclayInstitut Gustave RoussyCentre de recherche en Epidémiologie et Santé des PopulationsUniversity of UtahGeorge E. Wahlen Department of VA Medical CenterMayo Clinic in ArizonaInternational Epidemiology InstituteVanderbilt University Medical CenterChristus Santa Rosa Health SystemTampere UniversityTampere University HospitalTampere UniversityWashington University in St. LouisAarhus UniversityUniversity of Hawaiʻi at MānoaUniversity of Hawaii SystemCancer Center of HawaiiUniversity of Hawaii Cancer CenterMelbourne ClinicComplejo Hospitalario Universitario de SantiagoUniversidad de CantabriaInstituto de Investigación Marqués de ValdecillaConsorci Institut D'Investigacions Biomediques August Pi I SunyerUniversitat de BarcelonaCopenhagen University HospitalRigshospitaletKrebsregister SaarlandUniversity Hospital UlmUniversity Hospital Centre ZagrebUniversity of California San DiegoCentre for Cancer BiologyThe University of AdelaidePeter MacCallum Cancer CentreChris O’Brien LifehouseGarvan Institute of Medical ResearchSouth Australian Health and Medical Research InstituteFreemasons Foundation Centre for Men's HealthDiscovery InstituteThe Kinghorn Cancer Centre

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Prostate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentCancer-related molecular mechanisms research

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.